CytRx Corp – Company Profile & SWOT Analysis

CytRx Corp – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

CytRx Corp (CytRx) is a clinical stage is a biopharmaceutical company that focuses on the discovery, development and commercialization of new therapeutics for the treatment of cancer patients. CytRx’s lead product aldoxorubicin is in the late stage of clinical development and finds application in treating relapsed soft tissue melanoma, small-cell lung cancer and other types of cancer with unmet medical needs. The company also has other pipeline products being developed through Linker Activated Drug Release technology platform. CytRx is headquartered in Los Angeles, California, the US.

Scope

Detailed information on CytRx Corp required for business and competitor intelligence needs

A study of the major internal and external factors affecting CytRx Corp in the form of a SWOT analysis

An in-depth view of the business model of CytRx Corp including a breakdown and examination of key business segments

News about CytRx Corp, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of CytRx Corp and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess CytRx Corp as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on CytRx Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Sanofi

FirstString Research Inc

Seattle Genetics Inc

Pharmacyclics LLC

ZIOPHARM Oncology Inc

CTI BioPharma Corp

AstraZeneca Plc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

CytRx Corp - Key Facts

CytRx Corp - Key Employees

CytRx Corp - Key Employee Biographies

CytRx Corp - Major Products and Services

CytRx Corp - History

CytRx Corp - Company Statement

CytRx Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

CytRx Corp - Business Description

CytRx Corp - SWOT Analysis

SWOT Analysis - Overview

CytRx Corp - Strengths

CytRx Corp - Weaknesses

CytRx Corp - Opportunities

CytRx Corp - Threats

CytRx Corp - Key Competitors

Section 3 Company’s Lifesciences Financial Deals and Alliances

CytRx Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

CytRx Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

CytRx Corp, Recent Deals Summary

Section 4 Company’s Recent Developments

May 15, 2019: CytRx reports first quarter 2019 financial results

Mar 29, 2019: CytRx corporation reports 2018 financial results

Feb 11, 2019: CytRx highlights majority of cancer patients do not have targetable genetic mutations and are therefore candidates for chemotherapy

Dec 21, 2018: CytRx announces conclusion of pre-clinical phase for its albumin binding ultra high potency LADR drug candidates and accompanying companion diagnostic

Aug 06, 2018: CytRx Reports Second Quarter 2018 Financial Results

Jun 25, 2018: CytRx joins Russell Microcap Index

Jun 04, 2018: CytRx Launches Centurion BioPharma to Advance LADR Albumin Binding Ultra-High Potency Oncology Drug Candidates

May 08, 2018: CytRx announces First Quarter 2018 Financial Results

May 03, 2018: CytRx Names Eric L. Curtis as Its President and Chief Operating Officer

Apr 18, 2018: CytRx Presents Statistically Significant Breakthrough Data for Its Albumin Binding Ultra High Potency LADRâ„¢ Drug Candidates at the American Association for Cancer Research 2018 Annual Meeting

Section 5 Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

CytRx Corp, Key Facts

CytRx Corp, Key Employees

CytRx Corp, Key Employee Biographies

CytRx Corp, Major Products and Services

CytRx Corp, History

CytRx Corp, Subsidiaries

CytRx Corp, Key Competitors

CytRx Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

CytRx Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

CytRx Corp, Recent Deals Summary

List of Figures

List of Figures

CytRx Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

CytRx Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports